Anifrolumab

From IDWiki
Revision as of 14:26, 4 July 2025 by Aidan (talk | contribs) (Created page with "* Monoclonal antibody targeting type I interferon (IFN-I) receptor (IFNAR1) * Indicated for systemic lupus erythematosus * Adverse effects include: ** Upper respiratory tract infection ** Nasopharyngitis ** Infusion-related reaction ** Bronchitis ** Urinary tract infection ** Sinusitis ** Increased risk of herpes zoster Category:Monoclonal antibodies Category:Rheumatology")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
  • Monoclonal antibody targeting type I interferon (IFN-I) receptor (IFNAR1)
  • Indicated for systemic lupus erythematosus
  • Adverse effects include:
    • Upper respiratory tract infection
    • Nasopharyngitis
    • Infusion-related reaction
    • Bronchitis
    • Urinary tract infection
    • Sinusitis
    • Increased risk of herpes zoster
Retrieved from "https://idwiki.org/index.php?title=Anifrolumab&oldid=11180"
Powered by MediaWiki
Powered by Semantic MediaWiki